Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 01 - 14 tags : Als save search
China SXT Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Shares
Published: 2022-01-14 (Crawled : 23:00) - globenewswire.com
SXTC | $1.01 2.02% 1.98% 770K
|
Health Technology
| Email alert
Add to watchlist
offering als ces china
China SXT Pharmaceuticals, Inc. Adds Newly Developed Kuihuapan and Zhudanfen Advanced TCMP Products, and Announces the Expected Continuous Growth of Its Production Capacity of Luxuejin
Published: 2022-01-14 (Crawled : 21:00) - biospace.com/
SXTC | $1.01 2.02% 1.98% 770K
|
Health Technology
|
| O: 16.87%
H: 0.0%
C: 0.0%
als ces china growth
Algernon Pharmaceuticals Announces Positive Feedback from U.S. FDA for Phase 2b Ifenprodil Chronic Cough Study
Published: 2022-01-14 (Crawled : 15:00) - biospace.com/
AGNPF | $0.0708 178.69% 1.3K
|
Health Technology
|
| O: 9.2%
H: 0.0%
C: -4.78%
fda phase 2 als phase 2b positive chronic cough
Vanda Pharmaceuticals Settles HETLIOZ® Patent Litigation with MSN
Published: 2022-01-14 (Crawled : 14:00) - prnewswire.com
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
|
| O: -0.55%
H: 0.0%
C: 0.0%
hetlioz als patent
Pieris Pharmaceuticals Announces Dosing of First Patient in Phase 2 Gastric Cancer Trial of 4–1BB/HER2 Bispecific Cinrebafusp Alfa
Published: 2022-01-14 (Crawled : 14:00) - biospace.com/
PIRS | $0.1455 -6.25% -6.67% 1.9M
|
Health Technology
|
| O: -3.76%
H: 0.0%
C: 0.0%
phase 2 als trial cancer her2- her2
Worldwide Hospital Services Industry to 2027 - Rising Investment in Healthcare Infrastructure and Professionals Presents Opportunities
Published: 2022-01-14 (Crawled : 12:30) - prnewswire.com
THC | $93.19 2.32% 0.0% 1.1M
|
Health Services
|
| O: 1.58%
H: 0.0%
C: 0.0%
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: -0.7%
H: 0.0%
C: 0.0%
PHG | $19.98 0.0% 540K
|
Health Technology
|
| O: 2.51%
H: 0.0%
C: 0.0%
GE | News | $148.06 -3.19% 0.0% 9.5M
|
Electronic Technology
|
| O: -0.9%
H: 0.0%
C: 0.0%
CYH | $2.86 2.88% 0.0% 2M
|
Health Services
|
| O: 1.09%
H: 0.0%
C: 0.0%
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: 0.0%
A | $132.73 0.22% 0.0% 1.3M
|
Health Technology
|
| O: -3.36%
H: 0.0%
C: 0.0%
MMM | $92.27 0.86% -0.18% 3.6M
|
Producer Manufacturing
|
| O: -0.09%
H: 0.0%
C: -1.17%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.96%
H: 0.0%
C: 0.0%
health als ces thc services
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Reata Pharmaceuticals, Inc. - RETA
Published: 2022-01-14 (Crawled : 05:00) - prnewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: -1.17%
H: 3.88%
C: 3.38%
als ces deadline
Gulbrandsen Chemicals is now Gulbrandsen; Announces Official Launch of New Brand Tagline and Website
Published: 2022-01-14 (Crawled : 03:00) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: 3.01%
H: 0.0%
C: 0.0%
als brands ces
Television Personality Matt James Teams Up with Dymatize to Crush Fitness Goals in New Year
Published: 2022-01-14 (Crawled : 01:00) - postholdings.com
POST | $104.0 1.05% 0.0% 690K
|
Consumer Non-Durables
|
| O: 0.87%
H: 0.0%
C: 0.0%
BRBR | $53.98 -0.46% 0.0% 990K
|
Health Technology
|
| O: 3.63%
H: 0.0%
C: 0.0%
als
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.